# Bristol-Myers Squibb (BMY, BMY-R): who owns it

6 value investors held Bristol-Myers Squibb in their Q3 2026 13F, led by Kahn Brothers, Miller Value Partners, Tweedy, Browne, Horizon Kinetics, Mairs &…

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Kahn Brothers | 1.6% | $10.0m | Added +2.2% | 53 |
| Miller Value Partners | 0.9% | $4.0m | Unchanged | 10 |
| Tweedy, Browne | 0.2% | $2.2m | Added +44% | 5 |
| Horizon Kinetics | 0.0% | $2.6m | Trimmed -0.3% | 30 |
| Mairs & Power | 0.0% | $1.4m | Added +2.0% | 53 |
| Dodge & Cox | 0.0% | $2.4m | Trimmed -99% | 53 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-09 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sold | 6249 | $403k |
| 2026-08-25 | Holzer Phil M | SVP and Controller | Sold | 500 | $34k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/bmy). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.